Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
A Study to evaluate the effect of a high-fat... for Healthy volunteer
Wuhan Createrna Science and Technology Co., Ltd
Healthy volunteer
1 trial -
A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults
Otsuka Beijing Research Institute
Incomplete Response - Major Depressive Disorder (IR-MDD)
1 trial -
A clinical study of MK-1289 in healthy adult men (MK-1289-001)
Merck Sharp and Dohme
COVID-19 Infection
1 trial -
A clinical study of MK-1403 in healthy men (MK-1403-004)
Merck Sharp and Dohme
Atherosclerosis
1 trial -
A clinical study of MK-1403 in healthy people (MK-1403-002)
Merck Sharp and Dohme
Atherosclerosis
1 trial -
A clinical study of MK-2420 in healthy men (MK-2420-003)
Merck Sharp and Dohme
Rheumatoid arthritis
1 trial -
A clinical study of MK-2420 in healthy people (MK-2420-002)
Merck Sharp and Dohme
Rheumatoid arthritis
1 trial -
A clinical study of MK-2828 in healthy people (MK-2828-001)
Merck Sharp and Dohme
Atherosclerosis
1 trial -
A clinical study of MK-2828 in healthy people (MK-2828-002)
Merck Sharp and Dohme
Atherosclerosis
1 trial -
A clinical study of MK-3214 in healthy people (MK-3214-001)
Merck Sharp and Dohme
Hypercholesterolaemia
1 trial -
A clinical study of MK-3508 in healthy people (MK-3508-006)
Merck Sharp and Dohme
Respiratory syncytial virus infection
1 trial -
A clinical study of MK-4082 in healthy people (MK-4082-001)
Merck Sharp and Dohme
Weight management
1 trial -
A clinical study of MK-4646 in healthy people (MK-4646-002)
Merck Sharp and Dohme
HIV infection
1 trial -
A clinical study of MK-5661 and placebo in healthy people (MK-5661-006)
Merck Sharp and Dohme
Pain
1 trial -
A clinical study of MK-5661 in healthy people (MK-5661-007)
Merck Sharp and Dohme
Pain
1 trial -
A clinical study of MK-6050 in healthy people (MK-6050-001)
Merck Sharp and Dohme
Hidradenitis suppurativa
1 trial -
A clinical study of MK-6916 and placebo in healthy people (MK-6916-003)
Merck Sharp and Dohme
Acute and chronic Pain
1 trial -
A clinical study of MK-6916 in healthy people (MK-6916-002)
Merck Sharp and Dohme
Acute and Chronic Pain
1 trial -
A clinical study of MK-6916 in healthy people (MK-6916-006)
Merck Sharp and Dohme
Acute and chronic Pain
1 trial -
A clinical study of MK-7228 in healthy men (MK-7228-001)
Merck Sharp and Dohme
Atherosclerosis
1 trial -
A clinical study of the V540A vaccine in healthy adults (V540A-001)
Merck Sharp and Dohme
Human Papilloma virus
1 trial -
A clinical study of the V540C vaccine in healthy adults (V540C-003)
Merck Sharp and Dohme
Human Papilloma virus
1 trial -
A clinical trial of MK-1824 in healthy participants (MK-1824-001)
Merck Sharp and Dohme
Heart failure with preserved ejection fraction
1 trial -
A clinical trial of MK-4605 in healthy participants (MK-4605-001)
Merck Sharp and Dohme
Dementia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.